Clal Insurance Enterprises Holdings Ltd Purchases Shares of 1,000 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Clal Insurance Enterprises Holdings Ltd purchased 1,000 shares of Intuitive Surgical, Inc. valued at approximately $495,000, marking a significant investment in the medical equipment provider.
• Insider sales were notable, with CEO Gary S. Guthart selling 7,893 shares for about $3.94 million, resulting in a 37.44% decrease in his ownership.
• Analysts have mixed views on Intuitive Surgical's stock, with an average target price of $595.95, indicating a consensus rating of "Moderate Buy."

Clal Insurance Enterprises Holdings Ltd purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,000 shares of the medical equipment provider's stock, valued at approximately $495,000.

A number of other hedge funds have also recently bought and sold shares of ISRG. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG grew its holdings in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after purchasing an additional 883 shares in the last quarter. Townsquare Capital LLC grew its holdings in shares of Intuitive Surgical by 18.0% during the fourth quarter. Townsquare Capital LLC now owns 13,065 shares of the medical equipment provider's stock worth $6,820,000 after purchasing an additional 1,994 shares in the last quarter. Sagespring Wealth Partners LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $1,458,000. Finally, Advisors Capital Management LLC raised its position in Intuitive Surgical by 6.0% in the 4th quarter. Advisors Capital Management LLC now owns 2,912 shares of the medical equipment provider's stock worth $1,520,000 after purchasing an additional 165 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ISRG shares. BTIG Research upped their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Piper Sandler restated an "overweight" rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Finally, Citigroup restated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $595.95.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,859 shares of company stock valued at $7,908,248 over the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $5.27 during trading on Thursday, hitting $477.08. The company had a trading volume of 1,892,669 shares, compared to its average volume of 1,999,305. The stock has a 50 day simple moving average of $511.91 and a 200 day simple moving average of $526.80. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market capitalization of $171.02 billion, a P/E ratio of 66.54, a price-to-earnings-growth ratio of 5.01 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company earned $1.78 earnings per share. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.